ALIVUS
NSE#726 by turnoverAlivus Life Sciences Limited
₹1,350.90-19.10 (-1.39%)Close, 21 Aug 2026
2026-08-21O 1,365.60H 1,384.70L 1,331.10C 1,350.90
Key statistics
- Open
- ₹1,365.60
- Day range
- 1,331.10 – 1,384.70
- 52-week range
- 819.00 – 1,418.00
- From 52w high
- -4.7%
- Volume
- 69.4K
- Turnover
- ₹9.4Cr
- Delivery
- 45.1%
- Rel volume
- 0.40×
- RSI (14)
- 62.9
- ATR (14)
- 46.88
- SMA 50
- 1,190.68
- SMA 200
- 1,015.09
20-day avg 49.7%
Performance
- 1 day
- -1.39%
- 1 week
- -2.58%
- 1 month
- +22.50%
- 3 months
- +30.02%
- 6 months
- +49.88%
- 1 year
- +40.95%
Fundamentals
- Market cap
- ₹16,585 Cr
- P/E (TTM)
- 27.50
- EPS (TTM)
- ₹49.12
- Shares outstanding
- 12.27Cr
- Listed
- 6 Aug 2021
Q1 FY27
Classification
- Macro sector
- Healthcare
- Sector
- Healthcare
- Industry
- Pharmaceuticals & Biotechnology
- Basic industry
- Pharmaceuticals
NSE publishes no history for this taxonomy, so it is today’s classification rather than the one that held in the past.
Growthlatest filed quarter Q1 FY27
- Revenue YoY
- +6.41%
- Profit YoY
- +31.71%
- Revenue QoQ
- -7.07%
- Profit QoQ
- -1.59%
- Interest cost YoY
- +63.89%
Compound growth
| Annualised | 2y | 3y | 4y | 5y | 6y | 7y |
|---|---|---|---|---|---|---|
| Revenue | +6.3% | +4.8% | +5.5% | — | — | — |
| Profit | +16.2% | +6.9% | +9.0% | — | — | — |
Trailing-twelve-month figures against the same measure that many years earlier, on one reporting basis throughout. Blank where the filed history is too short or either end of the window was a loss — never a number built from less.
About
- ISIN
- INE03Q201024
- Series
- EQ
- History from
- 6 Aug 2021
- Sessions
- 1,250
Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 21 Aug 2026.